Dear researchers, what do you think about the idea of an inhalation therapy with Procain 1% or Lidocain 1% as an adjuvant therapy of viral pneumonia caused by SARS-CoV-2 in order to prevent ARDS?
Two very interesting links discussing the anti-inflammatory properties of local anesthetics:
Article Anti-inflammatory properties of local anesthetics and their ...
page 270, Cytokines
https://www.jlr.org/content/17/4/399.long